Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -17.95% is 177% below its 5-year average of -6.49%, near the low end of its 5-year range (-25.42%–24.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.23% above its 12-month average of -18.55%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -17.95%.
RETURN ON INVESTED CAPITAL (ROIC)
-17.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-18.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-19.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-6.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.23%
CURRENT VS 3Y AVG
+8.40%
CURRENT VS 5Y AVG
-176.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 555 covered companies
CURRENT VS SECTOR MEDIAN
+43.23%
vs the sector median at left
AbCellera Biologics Inc.
Market Cap
$4.16B
Return on Invested Capital (ROIC)
-17.95%
TTM Avg
-18.55%
3Y Avg
-19.60%
5Y Avg
-6.49%
Market Cap
$4.16B
Return on Invested Capital (ROIC)
10.24%
TTM Avg
7.56%
3Y Avg
2.02%
5Y Avg
-0.82%
Market Cap
$4.30B
Return on Invested Capital (ROIC)
-48.57%
TTM Avg
-35.38%
3Y Avg
-31.64%
5Y Avg
-25.98%
Market Cap
$3.97B
Return on Invested Capital (ROIC)
3.11%
TTM Avg
1.40%
3Y Avg
0.58%
5Y Avg
2.33%
Market Cap
$4.33B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$4.41B
Return on Invested Capital (ROIC)
N/A
TTM Avg
37.59%
3Y Avg
8.11%
5Y Avg
6.10%
Market Cap
$4.56B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-24.96%
3Y Avg
-29.08%
5Y Avg
-26.21%
Market Cap
$4.67B
Return on Invested Capital (ROIC)
-23.81%
TTM Avg
-42.00%
3Y Avg
-57.33%
5Y Avg
-55.42%
Market Cap
$4.68B
Return on Invested Capital (ROIC)
3.03%
TTM Avg
-0.36%
3Y Avg
-5.28%
5Y Avg
-5.99%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.16B | -17.95% | -18.55% | -19.60% | -6.49% |
| LivaNova PLC (LIVN)vs › | $4.16B | 10.24% | 7.56% | 2.02% | -0.82% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | -48.57% | -35.38% | -31.64% | -25.98% |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 3.11% | 1.40% | 0.58% | 2.33% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.33B | -23.69% | -46.07% | -46.68% | -46.68% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | N/A | 37.59% | 8.11% | 6.10% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.56B | -6.67% | -24.96% | -29.08% | -26.21% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.67B | -23.81% | -42.00% | -57.33% | -55.42% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 3.03% | -0.36% | -5.28% | -5.99% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | -18.48% | -32.11% | -33.07% | -32.00% |
ROIC
-17.9%
ROE
-18.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -17.95% |
| 2026-03-31 | -16.82% |
| 2025-12-31 | -16.80% |
| 2025-09-30 | -20.30% |
| 2025-06-30 | -20.87% |
| 2025-03-31 | -25.42% |
| 2024-12-31 | -24.52% |
| 2024-09-30 | -23.46% |
| 2024-06-30 | -20.06% |
| 2024-03-31 | -16.73% |
| 2023-12-31 | -17.33% |
| 2023-09-30 | -14.90% |
| 2023-06-30 | -8.20% |
| 2023-03-31 | -5.21% |
| 2022-12-31 | 10.09% |
| 2022-09-30 | 16.23% |
| 2022-06-30 | 13.89% |
| 2022-03-31 | 13.97% |
| 2021-12-31 | 11.95% |
| 2021-09-30 | 21.70% |
| 2021-06-30 | 24.52% |
| 2021-03-31 | 26.18% |
| 2020-12-31 | 17.29% |
| 2020-09-30 | -5.48% |
| 2020-06-30 | -4.13% |
| 2019-12-31 | -22.80% |
